annual total liabilities:
$454.96M+$137.76M(+43.43%)Summary
- As of today (August 4, 2025), ACAD annual total liabilities is $454.96 million, with the most recent change of +$137.76 million (+43.43%) on December 31, 2024.
- During the last 3 years, ACAD annual total liabilities has risen by +$295.74 million (+185.73%).
- ACAD annual total liabilities is now at all-time high.
Performance
ACAD Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$367.13M-$87.84M(-19.31%)Summary
- As of today (August 4, 2025), ACAD quarterly total liabilities is $367.13 million, with the most recent change of -$87.84 million (-19.31%) on March 31, 2025.
- Over the past year, ACAD quarterly total liabilities has dropped by -$23.93 million (-6.12%).
- ACAD quarterly total liabilities is now -19.31% below its all-time high of $454.96 million, reached on December 31, 2024.
Performance
ACAD quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ACAD Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.4% | -6.1% |
| 3 y3 years | +185.7% | +104.6% |
| 5 y5 years | +441.3% | +236.6% |
ACAD Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +185.7% | -19.3% | +107.7% |
| 5 y | 5-year | at high | +441.3% | -19.3% | +279.9% |
| alltime | all time | at high | >+9999.0% | -19.3% | +5932.3% |
ACAD Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $367.13M(-19.3%) |
| Dec 2024 | $454.96M(+43.4%) | $454.96M(+13.8%) |
| Sep 2024 | - | $399.69M(+0.6%) |
| Jun 2024 | - | $397.40M(+1.6%) |
| Mar 2024 | - | $391.06M(+23.3%) |
| Dec 2023 | $317.20M(+69.3%) | $317.20M(+17.3%) |
| Sep 2023 | - | $270.37M(+9.5%) |
| Jun 2023 | - | $246.98M(-12.1%) |
| Mar 2023 | - | $281.05M(+50.0%) |
| Dec 2022 | $187.40M(+17.7%) | $187.40M(+6.0%) |
| Sep 2022 | - | $176.81M(-0.6%) |
| Jun 2022 | - | $177.92M(-0.9%) |
| Mar 2022 | - | $179.45M(+12.7%) |
| Dec 2021 | $159.23M(+2.3%) | $159.23M(+5.6%) |
| Sep 2021 | - | $150.72M(-5.6%) |
| Jun 2021 | - | $159.59M(-8.1%) |
| Mar 2021 | - | $173.57M(+11.5%) |
| Dec 2020 | $155.61M(+85.1%) | $155.61M(+10.5%) |
| Sep 2020 | - | $140.80M(+45.7%) |
| Jun 2020 | - | $96.64M(-11.4%) |
| Mar 2020 | - | $109.07M(+29.8%) |
| Dec 2019 | $84.05M(+37.5%) | $84.05M(+10.2%) |
| Sep 2019 | - | $76.30M(+6.0%) |
| Jun 2019 | - | $71.97M(-13.0%) |
| Mar 2019 | - | $82.75M(+35.4%) |
| Dec 2018 | $61.12M(+24.2%) | $61.12M(+42.1%) |
| Sep 2018 | - | $43.02M(-14.4%) |
| Jun 2018 | - | $50.24M(+7.2%) |
| Mar 2018 | - | $46.87M(-4.8%) |
| Dec 2017 | $49.22M(+15.2%) | $49.22M(+35.3%) |
| Sep 2017 | - | $36.39M(-11.6%) |
| Jun 2017 | - | $41.17M(-9.5%) |
| Mar 2017 | - | $45.49M(+6.4%) |
| Dec 2016 | $42.74M(+93.1%) | $42.74M(+8.7%) |
| Sep 2016 | - | $39.33M(+34.6%) |
| Jun 2016 | - | $29.22M(+36.9%) |
| Mar 2016 | - | $21.34M(-3.6%) |
| Dec 2015 | $22.13M(+38.6%) | $22.13M(+23.1%) |
| Sep 2015 | - | $17.97M(-8.8%) |
| Jun 2015 | - | $19.72M(+16.9%) |
| Mar 2015 | - | $16.87M(+5.6%) |
| Dec 2014 | $15.97M | $15.97M(+41.6%) |
| Sep 2014 | - | $11.27M(+20.5%) |
| Jun 2014 | - | $9.36M(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $8.05M(+15.2%) |
| Dec 2013 | $6.99M(-70.4%) | $6.99M(-62.3%) |
| Sep 2013 | - | $18.53M(-27.1%) |
| Jun 2013 | - | $25.43M(+8.9%) |
| Mar 2013 | - | $23.35M(-1.1%) |
| Dec 2012 | $23.61M(+169.7%) | $23.61M(+287.9%) |
| Sep 2012 | - | $6.09M(-33.6%) |
| Jun 2012 | - | $9.17M(+2.6%) |
| Mar 2012 | - | $8.93M(+2.1%) |
| Dec 2011 | $8.75M(+0.5%) | $8.75M(-1.4%) |
| Sep 2011 | - | $8.88M(+4.6%) |
| Jun 2011 | - | $8.49M(-3.3%) |
| Mar 2011 | - | $8.78M(+0.8%) |
| Dec 2010 | $8.71M(-76.8%) | $8.71M(-75.8%) |
| Sep 2010 | - | $35.92M(-0.2%) |
| Jun 2010 | - | $36.01M(-0.5%) |
| Mar 2010 | - | $36.17M(-3.7%) |
| Dec 2009 | $37.57M(+221.5%) | $37.57M(-4.9%) |
| Sep 2009 | - | $39.51M(-9.5%) |
| Jun 2009 | - | $43.65M(+264.2%) |
| Mar 2009 | - | $11.98M(+2.6%) |
| Dec 2008 | $11.69M(-43.4%) | $11.69M(-2.3%) |
| Sep 2008 | - | $11.96M(-19.6%) |
| Jun 2008 | - | $14.88M(+1.5%) |
| Mar 2008 | - | $14.66M(-29.0%) |
| Dec 2007 | $20.65M(-7.8%) | $20.65M(+10.9%) |
| Sep 2007 | - | $18.61M(+16.7%) |
| Jun 2007 | - | $15.95M(-15.8%) |
| Mar 2007 | - | $18.95M(-15.3%) |
| Dec 2006 | $22.39M(-3.2%) | $22.39M(-0.6%) |
| Sep 2006 | - | $22.51M(-16.7%) |
| Jun 2006 | - | $27.02M(+14.2%) |
| Mar 2006 | - | $23.66M(+2.3%) |
| Dec 2005 | $23.14M(+138.9%) | $23.14M(+9.8%) |
| Sep 2005 | - | $21.07M(+68.8%) |
| Jun 2005 | - | $12.48M(-7.9%) |
| Mar 2005 | - | $13.55M(+39.9%) |
| Dec 2004 | $9.69M(-88.5%) | $9.69M(-6.8%) |
| Sep 2004 | - | $10.39M(-1.2%) |
| Jun 2004 | - | $10.51M(-87.8%) |
| Mar 2004 | - | $85.83M(+1.7%) |
| Dec 2003 | $84.36M(+50.3%) | $84.36M |
| Dec 2002 | $56.11M(+1269.6%) | - |
| Dec 2001 | $4.10M(-92.8%) | - |
| Dec 2000 | $56.62M | - |
FAQ
- What is ACADIA Pharmaceuticals Inc. annual total liabilities?
- What is the all time high annual total liabilities for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. annual total liabilities year-on-year change?
- What is ACADIA Pharmaceuticals Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. quarterly total liabilities year-on-year change?
What is ACADIA Pharmaceuticals Inc. annual total liabilities?
The current annual total liabilities of ACAD is $454.96M
What is the all time high annual total liabilities for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual total liabilities is $454.96M
What is ACADIA Pharmaceuticals Inc. annual total liabilities year-on-year change?
Over the past year, ACAD annual total liabilities has changed by +$137.76M (+43.43%)
What is ACADIA Pharmaceuticals Inc. quarterly total liabilities?
The current quarterly total liabilities of ACAD is $367.13M
What is the all time high quarterly total liabilities for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly total liabilities is $454.96M
What is ACADIA Pharmaceuticals Inc. quarterly total liabilities year-on-year change?
Over the past year, ACAD quarterly total liabilities has changed by -$23.93M (-6.12%)